Peripheral Neuropathy Secondary to Diabetes: DVA Secondary Claim

Peripheral neuropathy secondary to diabetes is a direct, single-factor secondary DVA claim. If diabetes mellitus is already accepted by DVA, and you have developed peripheral neuropathy as a consequence, the Statement of Principles for peripheral neuropathy contains a specific factor that establishes the link.

The SoP factor

The Peripheral Neuropathy SoP No. 72 of 2023 (Reasonable Hypothesis) contains factor 9(5): having an endocrine disease from the specified list at the time of the clinical onset of peripheral neuropathy. The specified list explicitly includes diabetes mellitus, encompassing both Type 1 and Type 2 diabetes. The Balance of Probabilities version is SoP No. 73 of 2023 with the equivalent factor.

The factor requires that diabetes mellitus was present at the time of clinical onset of the peripheral neuropathy. Once diabetes is accepted by DVA, this factor requires no additional proof of the diabetes itself — only confirmation that the neuropathy developed while the diabetes was present.

What type of neuropathy qualifies

This SoP covers non-traumatic disease of the peripheral nerves supplying the arms or legs, including mononeuritis multiplex. It excludes isolated mononeuropathies (such as carpal tunnel syndrome and ulnar neuropathy at the elbow), damage from trauma or nerve entrapment, and conditions such as Guillain-Barre syndrome and hereditary neuropathies.

Diabetic peripheral neuropathy — the classic stocking-and-glove pattern of sensory loss, tingling, numbness, and pain typically affecting feet and hands bilaterally — is exactly the condition this SoP covers.

Clinical features and diagnosis

Diabetic peripheral neuropathy typically presents with:

• Bilateral numbness or tingling starting in the feet, spreading proximally
• Burning or shooting pain, often worse at night
• Loss of protective sensation (unable to feel sharp or hot stimuli adequately)
• Loss of vibratory or proprioceptive sensation
• Weakness in advanced cases

The SoP requires symptoms plus either clinical signs or electrodiagnostic evidence (nerve conduction studies or electromyography). In practice a neurologist’s assessment with nerve conduction studies (NCS) and electromyography (EMG) is the strongest evidence. These tests measure conduction velocity and amplitude across peripheral nerves, distinguishing polyneuropathy from entrapment. A neurologist’s report confirming polyneuropathy consistent with a length-dependent pattern (feet worse than hands) is the key diagnostic document.

GARP M assessment

Peripheral neuropathy is assessed under GARP M’s neurological tables. The assessment considers sensory loss distribution, motor weakness, balance impairment, loss of protective sensation, and functional limitations on walking, standing, and fine motor tasks.

Mild neuropathy with predominant sensory symptoms and preserved strength attracts a lower rating. Moderate-to-severe neuropathy with significant sensory loss, motor weakness, and balance impairment can attract ratings of 20 to 30 points. Neuropathy causing loss of protective sensation in the feet creates significant long-term health risk and typically attracts a higher rating.

Further secondary claims from accepted neuropathy

Once peripheral neuropathy is accepted, it may anchor further secondary claims depending on its impact. Neuropathy causing balance impairment and falls risk may support a claim for consequences of those falls. Neuropathic pain is often severe and may contribute to a secondary depression or anxiety claim through the chronic pain pathways in those SoPs.

Frequently asked questions

My diabetes is accepted. Does it matter whether it's Type 1 or Type 2?

No. The specified list in the SoP says “diabetes mellitus” without qualification. Both Type 1 and Type 2 diabetes satisfy the factor.

Can I claim both peripheral neuropathy and other diabetic complications?

Yes. Diabetic retinopathy, nephropathy, and other complications may have their own SoPs and can be claimed separately. Each contributes its own impairment points under the relevant GARP M chapter. A comprehensive review of all diabetic complications is warranted once diabetes is accepted.

What if my neuropathy is in my feet only?

Diabetic peripheral neuropathy classically begins in the feet and is length-dependent — the longest nerves are affected first. Bilateral foot involvement consistent with a length-dependent polyneuropathy fully satisfies the SoP definition. The neuropathy does not need to affect the hands to qualify.

I have carpal tunnel syndrome. Is that covered by this SoP?

No. Carpal tunnel syndrome is an entrapment neuropathy (median nerve at the wrist) and is excluded from the peripheral neuropathy SoP. It has its own SoP. Diabetic patients do have higher rates of carpal tunnel syndrome, but those claims run through the Carpal Tunnel Syndrome SoP, not the Peripheral Neuropathy SoP.